Chia-Lin Wei - Nanopore sequencing reveals high-resolution structural variation in the cancer genome
Nanopore Community Meeting 2017
Dr. Wei joined the Jackson Laboratory in 2016 as the Director of Genomic Technologies, where she actively engages the development and application of innovative sequencing based genomic technologies to explore genome function and make genome-based medical discoveries for solutions in treating human disease. Dr. Wei got her Ph.D. (Microbiology) from University of California at Davis. Prior to that she was at the Joint Genome Institute (JGI), joining in 2010. She was responsible for Department of Energy (DOE) user facility genomic sequencing operation as well as sequencing related technology development effort within the Genomic Technology Department. Dr. Wei moved to JGI after an eight-year stint at Genome Institute of Singapore (GIS) and was responsible for establishing a sequencing technology platform and genome biology program. Dr. Wei group’s research activity involves the development of innovative sequencing-based genomic technologies to explore functional genomic elements for transcriptional and epigenetic regulation. She applies these approaches to interrogate genomic, characterize transcriptomes and chromatin structures.